Japanese regulatory authority's perspective on biosimilars

被引：12
|
作者：
Nagai, Sumimasa [1 ,2 ]
Yanagihara, Reiko [3 ]
Kishioka, Yasuhiro [4 ]
机构：
[1] Pharmaceut & Med Devices Agcy, Off New Drug 5, Tokyo, Japan
[2] Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Genet Therapeut, Tokyo 1088639, Japan
[3] Pharmaceut & Med Devices Agcy, Off Stand & Guidelines Dev, Tokyo, Japan
[4] Pharmaceut & Med Devices Agcy, Off Cellular & Tissue Based Prod, Tokyo, Japan
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 03期
关键词：
FOLLOW-ON BIOLOGICS;
D O I：
10.1016/S1470-2045(14)71220-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E101 / E101
页数：1
相关论文
共 50 条
  • [1] Japanese regulatory authority's perspective on biosimilars reply
    Bennett, Charles L.
    Chen, Brian
    Hermanson, Terhi
    Georgantopoulos, Peter
    Sartor, Oliver A.
    [J]. LANCET ONCOLOGY, 2015, 16 (03): : E102 - E102
  • [2] Health authority perspective on biosimilars
    Godman, Brian
    [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2013, 2 (01): : 10 - 11
  • [3] Iraqi regulatory authority current system and experience with biosimilars
    Al-Kinani, Khalid K.
    Ibrahim, Mazin J.
    Al-Zubaidi, Ruaa F.
    Younus, Manal M.
    Ramadhan, Samir H.
    Kadhim, Hussein J.
    Challand, Rodeina
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 117
  • [4] Biosimilars: a regulatory perspective from America
    Kay, Jonathan
    [J]. ARTHRITIS RESEARCH & THERAPY, 2011, 13 (03)
  • [5] Biosimilars: a regulatory perspective from America
    Jonathan Kay
    [J]. Arthritis Research & Therapy, 13
  • [6] Current Japanese Regulatory Systems for Generics and Biosimilars
    Kuribayashi, Ryosuke
    Sawanobori, Kenji
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (03) : 785 - 787
  • [7] Challenges for Streamlining the Development of Biosimilars: A Japanese Perspective
    Arato, Teruyo
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (01) : 30 - 36
  • [8] Safety assessment of biosimilars in Europe: a regulatory perspective
    Giezen, Thijs J.
    Schneider, Christian K.
    [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2014, 3 (04): : 180 - 183
  • [9] REGULATORY IMPLICATIONS - AN AUTHORITY PERSPECTIVE
    CARTWRIGHT, AC
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1991, 19 (02) : 465 - 467
  • [10] Regulatory toxicology from an authority perspective
    Kass, G. E.
    [J]. TOXICOLOGY LETTERS, 2022, 368 : S3 - S3
12345